Advising on new medicines for Scotland
Scottish Medicines Consortium (SMC) (scottishmedicines.org.uk) scores 68 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Government brands, in the 17th percentile of 10159 Healthcare brands.
Scottish Medicines Consortium (SMC) is a Scottish healthcare advisory body that evaluates the clinical and cost effectiveness of new medicines for NHS Scotland. It reviews evidence submitted by pharmaceutical companies, patient groups, and clinicians to produce advice aimed at ensuring equitable and consistent access to new treatments across Scotland's health service. SMC operates within the Healthcare and Government sectors, serving pharmaceutical companies, clinicians, patient advocacy groups, NHS Scotland stakeholders, and the wider public.
| Brand Name | Scottish Medicines Consortium (SMC) |
|---|---|
| Domain | scottishmedicines.org.uk |
| Industry | Healthcare, Government |
| Main Competitors | National Institute for Health and Care Excellence (NICE) (91/100), All Wales Medicines Strategy Group (AWMSG) (70/100), National Centre for Pharmacoeconomics (NCPE), Canadian Agency for Drugs and Technologies in Health (CADTH) (79/100), Pharmaceutical Benefits Advisory Committee (PBAC) |
Moz Domain Authority 52/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #910,448 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To provide advice on the clinical and cost effectiveness of new medicines to help ensure equitable access across Scotland's NHS." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: Microdata (Schema.org), og:title, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Facebook, Instagram; no detected presence on X (Twitter), LinkedIn, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Scottish Medicines Consortium (SMC)?", Claude could identify the brand as of September 2026. The Scottish Medicines Consortium is part of NHS Scotland and provides advice to health boards on the clinical and cost effectiveness of newly licensed medicines, helping decide whether they should be routinely available on the NHS in Scotland. Best known for Assessing new medicines for cost-effectiveness and advising NHS Scotland on their routine use.
When asked "Best brands similar to Scottish Medicines Consortium (SMC)?", Claude would recommend Scottish Medicines Consortium (SMC) as of September 2026. If someone is asking about health technology assessment bodies similar to NICE, SMC is a key comparable organization specific to Scotland.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Scottish Medicines Consortium (SMC)'s main competitors in Healthcare: National Institute for Health and Care Excellence (NICE) (91/100), All Wales Medicines Strategy Group (AWMSG) (70/100), Canadian Agency for Drugs and Technologies in Health (CADTH) (79/100).
Sources: Brand Analyzer scan
Scottish Medicines Consortium (SMC) has low AI-search visibility, scoring 23/100 on Brand Analyzer's AI visibility composite (visibility 5, trust 26, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Scottish Medicines Consortium (SMC) scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
SMC offers advisory assessments on the clinical and cost effectiveness of new medicines intended for use within NHS Scotland. These assessments incorporate evidence from pharmaceutical companies, clinical data, and patient group input, resulting in published advice used to inform medicine availability decisions across Scotland's healthcare system.
The Scottish Medicines Consortium (SMC) is a healthcare advisory body that provides guidance on the clinical and cost effectiveness of new medicines for NHS Scotland. It operates within the healthcare and government sectors and aims to ensure equitable access to new treatments across Scotland's health system.
Scottish Medicines Consortium (SMC) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
SMC's advice and processes are used by pharmaceutical companies seeking approval for new medicines, clinicians making treatment decisions, patient advocacy groups providing input on medicine evaluations, NHS Scotland stakeholders responsible for healthcare provision, and members of the public interested in medicine access decisions.
SMC is known for its role as Scotland's authoritative body for assessing new medicines before they are made available on NHS Scotland, incorporating clinical evidence alongside patient and public input into its decision-making process.
Scottish Medicines Consortium (SMC) scores 23/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Scottish Medicines Consortium (SMC) has a weak AI-visibility profile at 23/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is visibility (5/100). It benefits from a global traffic rank of #910,448 (Tranco), a Moz Domain Authority of 52/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and thin schema.org structured data. In a live check, Claude could already identify Scottish Medicines Consortium (SMC) from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Scottish Medicines Consortium (SMC): Sandnes kommune (68/100), Royal Life Saving Society - Australia (68/100), Senseonics (68/100), Serbanon (68/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.